I was at an ideas festival filled with some bright and accomplished people and I found myself rebuked by what I would consider true ignorance at least three times.
Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.
In my search for wisdom about aging, I maintain that the primary cause is telomere shortening. This does not mean that methylation, signaling with stem cell produced vesicles (like packages with a purpose) don’t play a secondary role.
I would like to recommend the TV show, Younger for its new take on telling women’s stories. Let’s hear it for the women who bravely face the challenges of balancing reproductive capacity, career, freedom, and having to tolerate men.
I have noted that over the last nine years, taking telomerase activators in my patients can lead to increases but that this does not result in continuous lengthening. Now, we understand why this is the case.
In this 62-minute, we have a cheerful and accessible discussion that nonetheless goes quite deeply into my Telomere/Stem Cell Theory of Aging- right down a breakdown of Koch’s Postulates (the foundation of establishing disease causation versus correlation), the nature of stem cells, and how to naturally live longer and healthier
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
